443 related articles for article (PubMed ID: 8432847)
1. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
3. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
Dieplinger H; Kronenberg F
Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
5. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
[TBL] [Abstract][Full Text] [Related]
6. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
Liu X; Sun L; Li Z; Gao Y; Hui R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) in health and disease.
Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H
Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
[TBL] [Abstract][Full Text] [Related]
12. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
Rader DJ; Cain W; Zech LA; Usher D; Brewer HB
J Clin Invest; 1993 Feb; 91(2):443-7. PubMed ID: 8432853
[TBL] [Abstract][Full Text] [Related]
13. [Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism].
Hubácek JA; Stávek P; Pit'ha J; Skodová Z; Poledne R
Cas Lek Cesk; 2001 Jun; 140(11):332-4. PubMed ID: 11431852
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
15. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels.
Horita K; Eto M; Saito M; Nakata H; Iwashima Y; Ito H; Takahashi M; Kondo A; Morikawa A; Makino I
Artery; 1993; 20(6):324-36. PubMed ID: 8010888
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
[TBL] [Abstract][Full Text] [Related]
20. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
Prins J; Leus FR; Bouma BN; van Rijn HJ
Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]